129 related articles for article (PubMed ID: 35150958)
1. Design, synthesis and biological evaluation of hydantoin derivatives as Mcl-1 selective inhibitors.
Liang X; Li X; Zhao Z; Nie Y; Yao Z; Ren W; Yang X; Hou X; Fang H
Bioorg Chem; 2022 Apr; 121():105643. PubMed ID: 35150958
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of dual Bcl-2/Mcl-1 inhibitors bearing 2-(1H-indol-4-yl)benzoic acid scaffold.
Niu Q; Deng H; Zhang Z; Xu Q; Luan S; Huang M; Liu D; Zhao L
Bioorg Med Chem Lett; 2021 Sep; 47():128215. PubMed ID: 34153472
[TBL] [Abstract][Full Text] [Related]
3. De novo design, synthesis and evaluation of benzylpiperazine derivatives as highly selective binders of Mcl-1.
Ding X; Li Y; Lv L; Zhou M; Han L; Zhang Z; Ba Q; Li J; Wang H; Liu H; Wang R
ChemMedChem; 2013 Dec; 8(12):1986-2014. PubMed ID: 24124106
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of tyrosine derivatives as Mcl-1 inhibitors.
Liu L; Liu R; Yang X; Hou X; Fang H
Eur J Med Chem; 2020 Apr; 191():112142. PubMed ID: 32088497
[TBL] [Abstract][Full Text] [Related]
5. Improved binding affinities of pyrrolidine derivatives as Mcl-1 inhibitors by modifying amino acid side chains.
Wan Y; Liu T; Li X; Chen C; Fang H
Bioorg Med Chem; 2017 Jan; 25(1):138-152. PubMed ID: 27810438
[TBL] [Abstract][Full Text] [Related]
6. Development of a series of novel Mcl-1 inhibitors bearing an indole carboxylic acid moiety.
Deng H; Huang M; Liu H; Zhang H; Liu L; Gao B; Li X; Li J; Niu Q; Zhang Z; Luan S; Zhang J; Jing Y; Liu D; Zhao L
Bioorg Chem; 2022 Oct; 127():106018. PubMed ID: 35901526
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and preliminary biological studies of pyrrolidine derivatives as Mcl-1 inhibitors.
Wan Y; Wang J; Sun F; Chen M; Hou X; Fang H
Bioorg Med Chem; 2015 Dec; 23(24):7685-93. PubMed ID: 26620718
[TBL] [Abstract][Full Text] [Related]
8. 1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation.
Xu G; Liu T; Zhou Y; Yang X; Fang H
Bioorg Med Chem; 2017 Oct; 25(20):5548-5556. PubMed ID: 28866374
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker.
Richard DJ; Lena R; Bannister T; Blake N; Pierceall WE; Carlson NE; Keller CE; Koenig M; He Y; Minond D; Mishra J; Cameron M; Spicer T; Hodder P; Cardone MH
Bioorg Med Chem; 2013 Nov; 21(21):6642-9. PubMed ID: 23993674
[TBL] [Abstract][Full Text] [Related]
10. Discovery and development of substituted tyrosine derivatives as Bcl-2/Mcl-1 inhibitors.
Liu R; Liu L; Liu T; Yang X; Wan Y; Fang H
Bioorg Med Chem; 2018 Sep; 26(17):4907-4915. PubMed ID: 30170927
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, stereochemical determination, molecular docking study, in silico pre-ADMET prediction and anti-proliferative activities of indole-pyrimidine derivatives as Mcl-1 inhibitors.
Lamie PF; Philoppes JN
Bioorg Chem; 2021 Nov; 116():105335. PubMed ID: 34509795
[TBL] [Abstract][Full Text] [Related]
12. Marinopyrrole derivatives with sulfide spacers as selective disruptors of Mcl-1 binding to pro-apoptotic protein Bim.
Cheng C; Liu Y; Balasis ME; Garner TP; Li J; Simmons NL; Berndt N; Song H; Pan L; Qin Y; Nicolaou KC; Gavathiotis E; Sebti SM; Li R
Mar Drugs; 2014 Jul; 12(8):4311-25. PubMed ID: 25076060
[TBL] [Abstract][Full Text] [Related]
13. Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins.
Kump KJ; Miao L; Mady ASA; Ansari NH; Shrestha UK; Yang Y; Pal M; Liao C; Perdih A; Abulwerdi FA; Chinnaswamy K; Meagher JL; Carlson JM; Khanna M; Stuckey JA; Nikolovska-Coleska Z
J Med Chem; 2020 Mar; 63(5):2489-2510. PubMed ID: 31971799
[TBL] [Abstract][Full Text] [Related]
14. Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitors.
Du J; Liu L; Liu B; Yang J; Hou X; Yu J; Fang H
Future Med Chem; 2020 Jul; 12(14):1293-1304. PubMed ID: 32397829
[No Abstract] [Full Text] [Related]
15. Discovery and development of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as Bcl-2/Mcl-1 inhibitors.
Liu R; Liu L; Yang X; Fang H
Bioorg Chem; 2019 Jul; 88():102938. PubMed ID: 31028992
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel indazole-acylsulfonamide hybrids as selective Mcl-1 inhibitors.
Wan Y; Li Y; Yan C; Wen J; Tang Z
Bioorg Chem; 2020 Nov; 104():104217. PubMed ID: 32911192
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors.
Li R; Cheng C; Balasis ME; Liu Y; Garner TP; Daniel KG; Li J; Qin Y; Gavathiotis E; Sebti SM
Eur J Med Chem; 2015 Jan; 90():315-331. PubMed ID: 25437618
[TBL] [Abstract][Full Text] [Related]
18. Discovery and structure-activity relationship studies of novel Bcl-2/Mcl-1 dual inhibitors with indole scaffold.
Zhang Z; Hou L; Bai L; Pei J; Zhao S; Luan S; Liu D; Huang M; Zhao L
Bioorg Chem; 2022 Aug; 125():105845. PubMed ID: 35512494
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of functional redundancy among anti-apoptotic Bcl-2 proteins and its role in cancer cell survival.
Eichhorn JM; Alford SE; Sakurikar N; Chambers TC
Exp Cell Res; 2014 Apr; 322(2):415-24. PubMed ID: 24556425
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and preliminary biological evaluation of indole-3-carboxylic acid-based skeleton of Bcl-2/Mcl-1 dual inhibitors.
Liu T; Wan Y; Liu R; Ma L; Li M; Fang H
Bioorg Med Chem; 2017 Mar; 25(6):1939-1948. PubMed ID: 28233676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
